Minnesota
Cancer surgery and procedure trials in Minnesota
101 cancer surgery and procedure studies are recruiting participants at sites in 46 cities across Minnesota as of November 18, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse Minnesota by city
Cities with the most studies recruiting right now.
Rochester
58 studies recruiting.
Minneapolis
49 studies recruiting.
Every Minnesota city with a recruiting study
By research area: Lymphoma (31), Breast Cancer (20), Lung Cancer (19), Prostate Cancer (15), Pancreatic Cancer (11), Melanoma (5).
Rochester (58), Minneapolis (49), Saint Paul (33), Coon Rapids (31), Duluth (31), Saint Louis Park (31), Edina (30), Deer River (28), Hibbing (28), Sandstone (28), Virginia (28), Bemidji (24), Brainerd (20), Maplewood (16), Woodbury (16), Shakopee (15), Waconia (15), Burnsville (14), Saint Cloud (14), Robbinsdale (12), Stillwater (11), Maple Grove (8), Monticello (7), New Ulm (7), Thief River Falls (7), Willmar (7), Worthington (7), Chaska (6), Detroit Lakes (6), Princeton (5), Wyoming (5), Albert Lea (4), Fosston (4), Park Rapids (4), Aitkin (3), Baxter (3), Cambridge (3), Crosslake (3), Ely (3), International Falls (3), Mankato (3), Moose Lake (3), Pequot Lakes (3), Pine River (3), Staples (3), Fridley (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Breast cancer: recently updated in Minnesota
Basic details from each study's public record (the 12 most recently updated of 101). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Phase 2
- All ages
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bemidji · Coon Rapids · Deer River · and 11 more U.S. locations
- Registry record
- NCT05564377 · updated
The Vanguard Study: Testing a New Way to Screen for Cancer
- No phase
- Ages 45 to 75
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Minneapolis
- Registry record
- NCT06995898 · updated
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bemidji · Brainerd · Coon Rapids · and 15 more U.S. locations
- Registry record
- NCT07391774 · updated
Source: ClinicalTrials.gov. Data processed . See every breast cancer study recruiting in Minnesota on ClinicalTrials.gov.
Lung cancer: recently updated in Minnesota
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Rochester
- Registry record
- NCT04665739 · updated
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bemidji · Brainerd · Coon Rapids · and 9 more U.S. locations
- Registry record
- NCT06498635 · updated
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Brainerd · Coon Rapids · Deer River · and 9 more U.S. locations
- Registry record
- NCT07388524 · updated
Source: ClinicalTrials.gov. Data processed . See every lung cancer study recruiting in Minnesota on ClinicalTrials.gov.
Prostate cancer: recently updated in Minnesota
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Deer River · Duluth · Edina · and 8 more U.S. locations
- Registry record
- NCT03866382 · updated
Source: ClinicalTrials.gov. Data processed . See every prostate cancer study recruiting in Minnesota on ClinicalTrials.gov.
Melanoma: recently updated in Minnesota
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bemidji · Brainerd · Burnsville · and 18 more U.S. locations
- Registry record
- NCT05136196 · updated
Source: ClinicalTrials.gov. Data processed . See every melanoma study recruiting in Minnesota on ClinicalTrials.gov.
Lymphoma: recently updated in Minnesota
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
- Phase 2
- Up to 365 days
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Minneapolis
- Registry record
- NCT06317662 · updated
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Brainerd · Burnsville · Coon Rapids · and 11 more U.S. locations
- Registry record
- NCT06337318 · updated
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Phase 1/2
- Up to age 22
- All sexes
- Sponsor
- PedAL BCU, LLC
- Recruiting in
- Minneapolis · Rochester
- Registry record
- NCT04726241 · updated
Source: ClinicalTrials.gov. Data processed . See every lymphoma study recruiting in Minnesota on ClinicalTrials.gov.
Pancreatic cancer: recently updated in Minnesota
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bemidji · Coon Rapids · Duluth · and 3 more U.S. locations
- Registry record
- NCT04858334 · updated
Source: ClinicalTrials.gov. Data processed . See every pancreatic cancer study recruiting in Minnesota on ClinicalTrials.gov.
Ask about studies in Minnesota
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a surgery or another procedure, as each study is coded in the registry.
Cancer Surgery Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections